Coupling of remote alternating-access transport mechanisms for protons and substrates in the multidrug efflux pump AcrB.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 25248080.
- Also identified by DOI 10.7554/eLife.03145 and PMC identifier 4359379.
- Licence recorded as CC0.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Membrane transporters of the RND superfamily confer multidrug resistance to pathogenic bacteria, and are essential for cholesterol metabolism and embryonic development in humans. We use high-resolution X-ray crystallography and computational methods to delineate the mechanism of the homotrimeric RND-type proton/drug antiporter AcrB, the active component of the major efflux system AcrAB-TolC in Escherichia coli, and one most complex and intriguing membrane transporters known to date. Analysis of wildtype AcrB and four functionally-inactive variants reveals an unprecedented mechanism that involves two remote alternating-access conformational cycles within each protomer, namely one for protons in the transmembrane region and another for drugs in the periplasmic domain, 50 Å apart. Each of these cycles entails two distinct types of collective motions of two structural repeats, coupled by flanking α-helices that project from the membrane. Moreover, we rationalize how the cross-talk among protomers across the trimerization interface might lead to a more kinetically efficient efflux system.
Medical subject headings
- Drug Resistance, Bacterial
- Escherichia coli
- Escherichia coli Proteins
- ATP-Binding Cassette, Sub-Family C Proteins